Fidelity Investments
ZURA icon

Fidelity Investments’s Zura Bio ZURA Stock Holding History

Fidelity Investments’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.12M Sell
528,284
-1,062
-0.2% -$5.06K ﹤0.01% 2597
2026
Q1 		$3.15M Buy
529,346
+42
+0% +$254 ﹤0.01% 2475
2025
Q4 		$2.77M Sell
529,304
-1,982
-0.4% -$7.84K ﹤0.01% 2491
2025
Q3 		$2.3M Sell
531,286
-37,853
-7% -$68.1K ﹤0.01% 2491
2025
Q2 		$598K Buy
569,139
+566,479
+21,296% +$677K ﹤0.01% 2896
2025
Q1 		$3.43K Buy
2,660
+1,672
+169% +$2.64K ﹤0.01% 4793
2024
Q4 		$2.47K Sell
988
-1,747
-64% -$6.22K ﹤0.01% 4788
2024
Q3 		$11.1K Buy
2,735
+427
+19% +$1.59K ﹤0.01% 4397
2024
Q2 		$8.08K Sell
2,308
-654
-22% -$2.67K ﹤0.01% 4403
2024
Q1 		$7.61K Buy
2,962
+1,769
+148% +$6.27K ﹤0.01% 4368
2023
Q4 		$5.57K Buy
1,193
+528
+79% +$2.64K ﹤0.01% 4413
2023
Q3 		$4.39K Buy
665
+382
+135% +$2.55K ﹤0.01% 4367
2023
Q2 		$2.32K Buy
+283
New +$2.27K ﹤0.01% 4554

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Fidelity Investments's ZURA Position: Q2 2026 in Review

Fidelity Investments reduced its Zura Bio (ZURA) stake by 0.2% in Q2 2026, selling an estimated $5.06K and leaving 528,284 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2597.

Fidelity Investments first reported a position in ZURA in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.15M in Q1 2026. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Fidelity Investments held 528,284 shares of Zura Bio worth $3.12M as of Q2 2026.
  • Fidelity Investments sold 1,062 Zura Bio shares in Q2 2026, an estimated $5.06K.
  • Zura Bio made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #2597 holding.
  • Fidelity Investments first reported a position in Zura Bio in Q2 2023 and has held it in 13 quarters since.
  • Fidelity Investments's Zura Bio position peaked at $3.15M in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.